Point-of-Care Ultrasound for Aesthetics & Plastic Surgery. Elevate Injection Safety and Surgical Precision with TodoPocus.

Imaging is identical — same transducers, frequencies, scan depths, and Doppler modes. The Pro Series upgrades endurance: a 4400 mAh battery doubles continuous scanning from 1.5 to 3 hours, and a heat-optimized Space Silver shell keeps the probe cool and comfortable through long vascular-mapping sessions, training days, and back-to-back clinics. If ultrasound is part of every consultation in your practice, the Pro pays for itself in uptime.

Standard software needle enhancement relies on acoustic reflection, which frequently fails during steep-angle insertions (>45°) or out-of-plane (OOP) approaches due to the physics of anisotropy. The L10H-Guide, however, utilizes passive magnetic sensors embedded in the probe to track a magnetized needle completely independent of the ultrasound beam. This projects a constant, real-time trajectory overlay on the screen, which clinical studies have shown reduces target distance errors by 57.1% and improves first-pass completion rates to 88.9% during complex nerve blocks.

Yes. TodoPocus wireless probes feature a minimum IP67 waterproof and dustproof design, with the transducer head specifically meeting IPX7 standards for liquid immersion. They are completely compatible with standard sterile surgical probe covers for use in the sterile field. Between cases, they can be safely and rapidly soaked or wiped down using hospital-approved high-level disinfectants and standard germicidal wipes, ensuring strict infection control compliance without risking internal electronic damage.

Ultra-high-frequency ultrasound reliably differentiates hyaluronic acid (HA) fillers, which appear as anechoic (dark) structures, from surrounding tissue and other biostimulators like calcium hydroxylapatite. This allows clinicians to perform precise, ultrasound-guided hyaluronidase injections directly into the HA deposit, rapidly restoring vascular perfusion and mitigating tissue necrosis safely.

Yes. High-frequency ultrasound readily distinguishes the sonographic signatures of different injectable products. Hyaluronic acid (HA) typically appears as well-defined, anechoic (black) fluid collections. In contrast, biostimulators like calcium hydroxylapatite (CaHA) or poly-L-lactic acid (PLLA) present as hyperechoic (bright) diffuse clouds, often with acoustic shadowing or bright particles. This diagnostic capability is invaluable when assessing unknown prior treatments or determining if a nodule can be effectively dissolved with hyaluronidase.

Aesthetic practitioners generally employ two complementary protocols: "Scan before injecting" and "Scan while injecting". The "Scan before" method is used prior to the procedure to map and mark the trajectory of critical vasculature, establishing safe injection zones. The "Scan while injecting" method utilizes real-time, in-plane imaging—often with a blunt cannula—to continuously visualize the instrument tip and the precise anatomical layer receiving the product, actively preventing intravascular placement.

Yes. Without ultrasound, clinicians must inject hyaluronidase blindly into the general area of suspected occlusion, often requiring multiple high-dose flooding treatments. Ultrasound guidance allows the practitioner to pinpoint the exact location and depth of the intravascular or compressive HA embolus. By targeting the hyaluronidase injection directly into the occlusion, clinicians can restore tissue perfusion much faster while utilizing significantly lower doses of the enzyme.